Close X
Attorney Spotlight

How does Jessie Zeigler anticipate the intersection of privacy and smart technology will impact the future of litigation? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Primary Care Providers Win Challenge of CMS Interpretation of Enhanced Payment Law

With the help and support of the Tennessee Medical Association, 21 Tennessee physicians of underserved communities joined together and retained Bass, Berry & Sims to file suit against the Centers for Medicare & Medicaid Services to stop improper collection efforts. Our team, led by David King, was successful in halting efforts to recoup TennCare payments that were used legitimately to expand services in communities that needed them. Read more

Tennessee Medical Association & Bass, Berry & Sims

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Healthcare Private Equity Compliance Checklist

The complex and ever-changing healthcare regulatory and enforcement environment, including increased focus on the role of private equity firms in their portfolio companies, make compliance a top priority for private equity firms investing in healthcare companies. The best way to limit your exposure as a private equity firm is to avoid a compliance misstep in the first place. Additionally, an effective and robust compliance program for your portfolio healthcare company makes it much more attractive to potential buyers and helps you avoid an unexpected and costly investigation or valuation hit down the road. Download the Healthcare Private Equity Compliance Checklist to assess whether your portfolio company's compliance program is up-to-date.

Click here to download the checklist.

Cables

Intellectual Property Litigation

Intellectual property (IP) and technology are major sources of income for companies – and, also, frequent causes for litigation. From complex patent litigation to trademark and interference matters before the U.S. Patent and Trademark Office (USPTO), companies need a comprehensive team of litigators that offer strategic vision, technical backgrounds and depth of experience. Our experienced IP litigation team handles an array of IP disputes for market leaders, fast-growing startups and individual innovators across many industries and a broad range of technologies at the bargaining table and at trial.

Our team manages all aspects of intellectual property disputes, assisting clients as both plaintiffs and defendants in connection with IP matters related to:

  • Patent
  • Trademark
  • Proceedings Before the Patent Trial and Appeal Board (PTAB), including inter partes review and post-grant review
  • Interferences and derivation related proceedings
  • Trade dress
  • Copyright infringement 
  • Unfair competition
  • False advertising
  • Misappropriation of trade secrets 
  • Antitrust
  • Data privacy
  • Counterfeiting

The IP litigation team brings together subject matter professionals that have advanced degrees and technical backgrounds in a variety of scientific and technical fields, including pharmaceuticals; chemistry; medical devices; computer science; internet commerce; consumer electronics; telecommunications; automotive systems; healthcare; and electrical, mechanical and chemical engineering.  Armed with a remarkable command of the courtroom, our seasoned litigators are able to leverage this technical knowledge to develop a novel case strategy and execute on behalf of our clients before federal agencies and at trial.  

Our IP litigation team regularly represents clients in federal and state courts, at both the trial and appellate level, as well as before the U.S. Patent and Trademark Office (USPTO), the U.S. International Trade Commission, and the American Arbitration Association. Our IP litigators consistently have been successful in the federal courts where IP disputes are most often litigated, including appearances in more than 15 U.S. District Courts during the last five years. Our IP litigation attorneys also serve both as advocates and as neutrals in alternative dispute resolution proceedings. 

As the Leahy-Smith America Invents Act continues to shape the landscape of patent law, our attorneys vigorously represent both petitioners and patent owners in post-grant proceedings before the PTAB and have experience utilizing the new procedures in conjunction with our overall defense strategy. Our team’s breadth of experience in patent litigation matters, combined with our patent prosecution experience before the USPTO, enables us to help our clients successfully navigate the intricacies of the PTAB’s procedural rules, including those related to inter partes review (IPR), post-grant review (PGR) and covered business method (CBM) proceedings.

Our IP team also conducts IP clearance, validity, infringement, and enforceability analyses for clients, including a thorough counseling on the nuances of IP procurement, product development, attorney-client privilege and attorney work product doctrines. We provide a comprehensive approach that helps our clients achieve their business goals, protect their rights and resolve their intellectual property disputes in an efficient and cost-effective manner.


News

View More

Related Experiences

View More

Related Professionals

NAME TITLE TELEPHONE CONTACT

Viewing 0 of 0 Results

View More

Publications

View More

Past Events

View More

Media Mentions

View More

Services

×

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.